Page last updated: 2024-09-03

glabridin and Adenocarcinoma

glabridin has been researched along with Adenocarcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jen, SH; Wei, MP; Yin, AC1
Hou, MF; Hsu, YL; Hung, CH; Jong, YJ; Kuo, PL; Lee, JN; Liang, HL; Tsai, EM; Wu, LY1

Other Studies

2 other study(ies) available for glabridin and Adenocarcinoma

ArticleYear
The Combinatory Effects of Glabridin and Tamoxifen on Ishikawa and MCF-7 Cell Lines.
    Natural product communications, 2015, Volume: 10, Issue:9

    Topics: Adenocarcinoma; Breast Neoplasms; Cell Line, Tumor; Drug Therapy, Combination; Endometrial Neoplasms; Estrogens; Female; Humans; Isoflavones; Phenols; Phytoestrogens; Selective Estrogen Receptor Modulators; Tamoxifen

2015
Glabridin, an isoflavan from licorice root, inhibits migration, invasion and angiogenesis of MDA-MB-231 human breast adenocarcinoma cells by inhibiting focal adhesion kinase/Rho signaling pathway.
    Molecular nutrition & food research, 2011, Volume: 55, Issue:2

    Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Migration Assays; Cell Movement; Cells, Cultured; Endothelium, Vascular; Female; Focal Adhesion Protein-Tyrosine Kinases; Glycyrrhiza; Humans; Isoflavones; Mice; Mice, Nude; Phenols; Plant Roots; Random Allocation; rhoA GTP-Binding Protein; Signal Transduction; Xenograft Model Antitumor Assays

2011